对于Mu阿片类受体偏向激素的预测模型
Fernando J Tun-Rosado1, Elier E Abreu-Martínez2, Axel Magdaleno-Rodriguez1
1Instituto de Química, Unidad Mérida, Universidad Nacional Autónoma de México, Carretera Mérida-Tetiz Km. 4.5, Ucú, Yucatán 97357, México.
Biochemistry
|April 10, 2025
概括
开发更安全的阿片类药物疗法需要理解mu-opioid受体 (MOR) 偏倚的激素. 这项研究分析了偏向的MOR激动剂,揭示了更安全的药物设计的关键分子特征和相互作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 计算生物学 计算生物学
背景情况:
- 类阿片受体 (MOR) 对于缓解疼痛至关重要,但与不良影响有关.
- 偏差激进主义提供了一种策略,通过选择性地激活所需的信号通路来开发更安全的MOR向治疗方法.
研究的目的:
- 通过使用新型数据库,全面分析mu-阿片类受体偏向激动剂.
- 识别控制偏差信号的关键分子特征和相互作用.
- 为预测药物设计评估偏向的MOR配体的可建模性.
主要方法:
- 策划了一个数据库 (BiasMOR) 的166个独特的偏见的MOR激动剂与注释的测试数据 (GTPγS,cAMP,β-arrestin).
- 进行了先进的结构-活动关系 (SAR) 分析,包括网络相似度图和活动悬崖识别.
- 使用RMODI和SARI指数评估模拟性,并分析了关键残留物相互作用 (例如D3.32,Y7.43,Y3.33).
主要成果:
- 确定了关键的分子特征和相互作用模式,负责MOR偏差信号传输.
- 已证明对偏向的MOR配体进行预测建模具有很高的适用性 (RMODI > 0.96).
- 突出了特定残留物和异构体特定相互作用在调节信号传输中的作用.
结论:
- 计算和实验方法可以促进对MOR偏差信号的理解.
- 偏差MOR数据库作为设计新型,更安全的偏差MOR连接体的基础.
- 确定偏向激动剂的结构特征是开发更安全的阿片类药物治疗方法的关键.
相关概念视频
Opioid Receptors: Overview
358
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
358
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
The Two-State Receptor Model
1.8K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.8K
Analgesia and Pain Management
403
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
403
Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
183
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
183


